Mutations in the von Hippel Lindau (VHL) gene are responsible for the VHL disease, an autosomal dominant cancer syndrome that predisposes to various benign and malignant tumors, including clear cell Renal Cell Carcinoma (ccRCC), hemangioblastoma or pheochromocytoma [1,2]. This evidence concerns the gene VHL and clear cell renal carcinoma.